Bone marrow (BM) involvement is common in patients with small cell lung cancer (SCLC) although it is still not clear whether it is of prognostic value in this disease. In one study , BM metastases had little prognostic value, since the difference in survival rates (8 months versus 10 for patients with no BM involvement detected) was not statistically significant. In other series, BM involvement predicted a significantly lower median duration of response and median survival time (Hirsch & Hansen, 1980) .
From a therapeutic point of view, BM involvement is known to increase haematological toxicity of conventional treatment (Hirsch & Hansen, 1980) . Furthermore, undetectable BM tumour cells may be the cause of some of the relapses observed after intensive chemotherapy followed by autologous BM transplantation in SCLC (Spitzer et al., 1986; Humblet et al., 1987) . Thus, knowledge of BM involvement at the time of diagnosis in SCLC is of great importance.
Routine detection of BM metastases in SCLC usually consists of unilateral posterior iliac crest aspiration and biopsy. With this procedure, BM involvement is found in 15-30% of patients (Hirsch & Hansen, 1980; Ihde & Hansen, 1981; Hansen et al., 1978; Hirsch et al., 1977; Anner & Drewinko, 1977; Choi & Carey, 1976; Holoye et al., 1977) . However, BM infiltration is detected in 35-66% of patients at necropsy (Kristjansen et al., 1986; Ihde et al., 1979) . Furthermore, among SCLC patients with negative BM biopsy, BM involvement is seen in 8-11% with the use of in vitro semi-solid culture techniques (Carney et al., 1980; Pollard et al., 1981; Neumann et al., 1984; Canon et al., 1988) , 22% with discontinuous gradient sedimentation method (Hunter et al., 1987) and 50% with BM aspirates immunostained with monoclonal antibodies (MoAB) (Stahel et al., 1985 and neuroblastoma (Couanet & Jeoffray, 1988 Cvtological and histological examination of the BM In all patients, unilateral posterior iliac crest aspiration and biopsy were performed before treatment. Several smears were made from the aspirate and cytologic examination was done after Wright coloration.
The biopsies were performed according to the method described by Jamshidi & Swaim (1971) with a median length of 2.5cm and touch imprints made from each biopsy. After decalcification, pathological slices were prepared with Haematoxylin and Eosin staining before light microscopic examination.
MoAB immunostaining
In 33 of 35 patients, 2-3 ml of aspirated marrow were mixed with heparin and mononuclear BM cells were immediately obtained by Ficoll separation for immunological analysis. Two MoABs of the immunoglobulin (Ig) G isotype (UJ 13 A kindly provided by J. Kemshead, 11.14 kindly provided by J.C. Laurent, SANOFI) recognise antigens expressed by cells of neuroectodermal origin (Favrot et al., 1986; Rosier & Laurent, 1987) , and CD45 of the IgM isotype (kindly provided by G. Janossy) recognises the panleucocyte antigen (Kemshead et al., 1983; Maritaz et al., 1988 MR examinations were considered to be positive or negative depending on the presence or absence of focal areas of low signal intensity within an area of normal signal intensity corresponding to marrow fat, as already described in malignant lymphoma (Shields et al., 1987) and in SCLC (Trillet et al.. 1988 These results are consistent with the conclusions of Hirsch and co-workers (Hirsch et al., 1977) on a group of 203 SCLC patients where BM aspiration was shown to be more effective than BM biopsy in detecting BM metastases in SCLC. On the contrary, Lawrence (Lawrence et al., 1984) claimed that histological examination of the BM was superior. when long enough BM specimens were obtained, that is, with the use of the Jamshidi needle instead of the shorter Radner needle used by the Danish group. But in most instances, his patients underwent a second and even a third biopsy 'through the same skin incision from a location of a few millimeters lateral to the first'. This is in accordance with previous reports on many neoplastic diseases (Brunning et al., 1975) including SCLC (Hirsch et al., 1979) which demonstrate that the number of positive BM aspirates and biopsies increases with bilateral examination of the BM. The rate of detection of BM involvement is clearly related to the total amount of BM tissue analysed and this is thought to result from the focal pattern of BM invasion by malignant cells (Lawrence et al., 1984 Immunological analysis is a highly sensitive method and allows detection of malignant cells in roughly 50% SCLC patients using MoABs directed against SCLC cells surface antigens like SMI (Stahel et al., 1985) or MOC (Postmus, personal communication RBS is a highly sensitive but very non-specific test in SCLC (Levenson et al., 1981) . In our study, all RBS-positive patients also had a positive MRI, except for three cases where bone metastases were detected outside the MRI field of view. In contrast, in five patients with positive MRI. RBS was negative. MRI focal areas of low intensity are located in the fat tissue, that is, in BM itself (Porter et al.. 1986 ). In contrast, RBS abnormalities reflect cortical bone involvement. Therefore, no comparison can be made between these two methods in terms of sensitivity and specificity. However, the lack of bone metastases detected with RBS and CT bone scan in MRI-positive areas might reflect different patterns of BM and cortical bone involvement in SCLC. According to our results with MRI, metastatic spread in the BM could be an earlier event than cortical bone involvement with SCLC. This sequence of bone invasion is concordant with the figures shown in our study: the rate of BM metastases detected with MRI (50%) is greater than the usual rate of bone metastases (30-35% in most series) (Ihde & Hansen. 1981) .
The necessity of BM sampling in SCLC has recently been questioned by some authors (Campling et al.. 1986 
